T1	Participants 18 26	neonate:
T2	Participants 212 266	critically ill neonates during the first week of life.
T3	Participants 285 442	200 neonates (gestational ages 26.4-41 weeks) treated with netilmicin (4-5 mg/kg in extended dosing intervals) for postnatal sepsis in the first week of life
T4	Participants 831 864	critically ill neonates >32 weeks
T5	Participants 959 977	neonates <32 weeks
T6	Participants 1121 1154	critically ill neonates >32 weeks
